Abbott
Abbott poised to take top spot in India
May 21, 2010Sales and Marketing Abbott, India, Piramal, em
Abbott has acquired Indian firm Piramal’s Healthcare Solutions business in a deal that is set to make it the number …
Abbott strikes emerging markets deal
May 12, 2010Sales and Marketing Abbott, Zydus Cadila, em
Abbott is seeking to extend its reach into emerging markets with a new collaboration with India-based pharma company Zydus Cadila. …
Abbott chief exec ordered to hand over email records
April 14, 2010Sales and Marketing Abbott, conduct
A US judge has ordered Abbott to give prosecutors access to company emails, including those sent by chief executive Miles …
Abbott boosts pipeline with biotech acquisition
March 10, 2010Research and Development, Sales and Marketing Abbott, Facet Biotech, daclizumab, volociximab
Abbott is to acquire US company Facet Biotech in a $450 million deal that will boost its oncology and immunology …
Abbott completes Solvay acquisition
February 16, 2010Sales and Marketing Abbott, Solvay
Abbott has completed its $6.2 billion acquisition of Solvay’s pharma division.The acquisition is expected to add $2.9 billion to Abbott’s …
Abbott’s weight-loss drug suspended in Europe
January 25, 2010Sales and Marketing Abbott, Reductil
Doctors have been told not to prescribe Abbott’s weight-loss treatment sibutramine after a safety review found evidence of serious cardiovascular …
Pharma mergers and acquisitions in 2009
December 22, 2009Research and Development, Sales and Marketing Abbott, GSK, J&J, JJ, M&A, MA, Novartis, Pfizer, Wyeth, generics, industry, merger, year in review
This year saw two ‘mega mergers’ in the sector, the acquisition of Wyeth by Pfizer and the reverse takeover of …
Digital Pharma: Byte-sized roundup
December 4, 2009Medical Communications Abbott, GE Healthcare, HES, NICE, Twitter, digi, digital pharma
Last week it was the ABPI that joined Twitter this week it’s UK cost effectiveness watchdog
Abbott buys Solvay for $6.6 billion
September 28, 2009Sales and Marketing Abbott, Solvay, cystic fibrosis
Abbott is to buy the pharma division of Belgium-based Solvay for 4.5 billion euros ($6.6 billion) in cash.Solvay declared in …
Depakote’s decline depresses Abbott
July 16, 2009Sales and Marketing Abbott
A rapid drop in sales for epilepsy drug Depakote cast a shadow over second quarter results from Abbott Laboratories. While …
Working Life: Alex Earley
December 17, 2008Abbott, Working Life
How did you find your way into your current role?After graduating, I worked as a clinical dietitian for the NHS …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
